The listing of Concord Medical Services' subsidiary on the Hong Kong Stock Exchange is likely to have a positive short-term impact on CCM's stock price. The IPO proceeds can be used for further growth and expansion, which investors may view favorably. However, the impact may be somewhat mitigated by the fact that the listing is occurring outside of the US market, and the direct benefits to CCM may not be immediately clear to all investors.